Amsterdam The medical technology manufacturer Phillips According to his own statements, he is again having difficulties with some ventilators. This time it is about machines that have already been replaced, according to a statement from the US pharmaceutical regulator FDA. According to the announcement, the company informed the FDA that the insulating foam could come loose and thus reduce the ventilation pressure.
Philips had replaced more than four million ventilators in the past 18 months over concerns the foam could emit toxins. A Philips spokesman said on Monday that the new difficulties could potentially affect devices of the Trilogy 100/200 type, which is around three percent of the models previously exchanged.
Top jobs of the day
Find the best jobs now and
be notified by email.